Infographic: the use of ELISpot assays for evaluating the safety of therapeutic drugs

After dosing with a drug, patient immune systems can mount anti-drug responses, which include humoral and cellular immunogenicity. Explore this ELISpot assay workflow to discover more about current guidelines and some common areas of concern.

BZ BioAgilytix Infographic-compressed

[Illustrated by Tobias Dumbraveanu]

In association with: